2-[(3R)-4-(5-chlorothiophen-2-yl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid

C27H27ClN6O5S2 — CID 67411256

IUPAC2-[(3R)-4-(5-chlorothiophen-2-yl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid
SMILESCCCc1ccc(CNC(=O)[C@H]2CN(c3cnc4cncc(C(=O)O)c4n3)CCN2S(=O)(=O)c2ccc(Cl)s2)cc1
InChIInChI=1S/C27H27ClN6O5S2/c1-2-3-17-4-6-18(7-5-17)12-31-26(35)21-16-33(10-11-34(21)41(38,39)24-9-8-22(28)40-24)23-15-30-20-14-29-13-19(27(36)37)25(20)32-23/h4-9,13-15,21H,2-3,10-12,16H2,1H3,(H,31,35)(H,36,37)/t21-/m1/s1
InChIKeyNZTHCHLBOBOTOC-OAQYLSRUSA-N
MW615.14 g/mol
LogP3.59
Rot. Bonds9

About 2-[(3R)-4-(5-chlorothiophen-2-yl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid

2-[(3R)-4-(5-chlorothiophen-2-yl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid (PubChem CID 67411256) has the molecular formula C27H27ClN6O5S2 and a molecular weight of 615.14 g/mol. Its IUPAC name is 2-[(3R)-4-(5-chlorothiophen-2-yl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid.

Molecular Properties

Compound Name2-[(3R)-4-(5-chlorothiophen-2-yl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid
PubChem CID67411256
Molecular FormulaC27H27ClN6O5S2
Molecular Weight615.14 g/mol
Exact Mass614.12
IUPAC Name2-[(3R)-4-(5-chlorothiophen-2-yl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid
SMILESCCCc1ccc(CNC(=O)[C@H]2CN(c3cnc4cncc(C(=O)O)c4n3)CCN2S(=O)(=O)c2ccc(Cl)s2)cc1
InChIInChI=1S/C27H27ClN6O5S2/c1-2-3-17-4-6-18(7-5-17)12-31-26(35)21-16-33(10-11-34(21)41(38,39)24-9-8-22(28)40-24)23-15-30-20-14-29-13-19(27(36)37)25(20)32-23/h4-9,13-15,21H,2-3,10-12,16H2,1H3,(H,31,35)(H,36,37)/t21-/m1/s1
InChIKeyNZTHCHLBOBOTOC-OAQYLSRUSA-N
XLogP3.59
TPSA145.69 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds9
Heavy Atoms41
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500615.14
LogP ≤ 53.59
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Analyze 2-[(3R)-4-(5-chlorothiophen-2-yl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[4-(5-chlorothiophen-2-yl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid
CID 67411259
3-[(3R)-4-(4-ethylphenyl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]quinoxaline-5-carboxylic acid
CID 67410264
2-[3-[[4-(1,1-difluoropropyl)phenyl]methylcarbamoyl]-4-[4-(trifluoromethoxy)phenyl]sulfonylpiperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid
CID 67408995
1-(5-chlorothiophen-2-yl)sulfonyl-4-pteridin-7-ylpiperazine-2-carboxylic acid
CID 91184306
(2S)-1-(5-chlorothiophen-2-yl)sulfonyl-N-[(4-hydroxyphenyl)methyl]pyrrolidine-2-carboxamide
CID 118467207
(2S)-N-[[4-[(5-chloro-3-pyridinyl)oxymethyl]phenyl]methyl]-1-(5-chlorothiophen-2-yl)sulfonylpyrrolidine-2-carboxamide
CID 118413767
(2R)-N-[(4-chlorophenyl)methyl]-4-pteridin-7-yl-1-[4-(trifluoromethoxy)phenyl]sulfonylpiperazine-2-carboxamide
CID 67408649
(2R)-1-(4-bromophenyl)sulfonyl-N-[[4-(1,1-difluoropropyl)phenyl]methyl]-4-pteridin-7-ylpiperazine-2-carboxamide
CID 67408820
4-methyl-2-[(3R)-3-[(4-propan-2-ylphenyl)methylcarbamoyl]-4-(4-propylphenyl)sulfonylpiperazin-1-yl]-1,3-thiazole-5-carboxamide
CID 67410797
(2R)-4-(2-oxo-1,4-dihydropyrazino[2,3-d][1,3]oxazin-7-yl)-N-[(4-propylphenyl)methyl]-1-[4-(trifluoromethoxy)phenyl]sulfonylpiperazine-2-carboxamide
CID 67411704
4-methyl-2-[3-[(4-propylphenyl)methylcarbamoyl]-4-[4-(trifluoromethoxy)phenyl]sulfonylpiperazin-1-yl]-1,3-thiazole-5-carboxylic acid
CID 67411113
6-[3-[(4-propylphenyl)methylcarbamoyl]-4-[4-(trifluoromethoxy)phenyl]sulfonylpiperazin-1-yl]pyridazine-3-carboxylic acid
CID 67411940

Frequently Asked Questions

What is the IUPAC name of 2-[(3R)-4-(5-chlorothiophen-2-yl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid?
The IUPAC name of 2-[(3R)-4-(5-chlorothiophen-2-yl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid (CID 67411256) is 2-[(3R)-4-(5-chlorothiophen-2-yl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid.
What is the SMILES notation for 2-[(3R)-4-(5-chlorothiophen-2-yl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid?
The canonical SMILES for 2-[(3R)-4-(5-chlorothiophen-2-yl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid is CCCc1ccc(CNC(=O)[C@H]2CN(c3cnc4cncc(C(=O)O)c4n3)CCN2S(=O)(=O)c2ccc(Cl)s2)cc1.
What is the InChIKey of 2-[(3R)-4-(5-chlorothiophen-2-yl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid?
The InChIKey is NZTHCHLBOBOTOC-OAQYLSRUSA-N. The full InChI is InChI=1S/C27H27ClN6O5S2/c1-2-3-17-4-6-18(7-5-17)12-31-26(35)21-16-33(10-11-34(21)41(38,39)24-9-8-22(28)40-24)23-15-30-20-14-29-13-19(27(36)37)25(20)32-23/h4-9,13-15,21H,2-3,10-12,16H2,1H3,(H,31,35)(H,36,37)/t21-/m1/s1.
What are the key properties of 2-[(3R)-4-(5-chlorothiophen-2-yl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid?
2-[(3R)-4-(5-chlorothiophen-2-yl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid has a molecular weight of 615.14 g/mol, XLogP of 3.59, 9 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(3R)-4-(5-chlorothiophen-2-yl)sulfonyl-3-[(4-propylphenyl)methylcarbamoyl]piperazin-1-yl]pyrido[3,4-b]pyrazine-8-carboxylic acid is sourced from PubChem (CID 67411256), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).